Last update:
Medications news
Medications
Combined therapy makes headway for liver cancer
A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety, according to results of a phase two ...
16 hours ago
0
52
Medications
Leprosy drug may be effective in Huntington's disease, study suggests
A preclinical study from Karolinska Institutet offers hope for treating severe neurodegenerative diseases with an existing drug. The study suggests that the leprosy drug clofazimine may be effective in the treatment of Huntington's ...
16 hours ago
0
56
Competition from 'skinny label' generics saved medicare billions, according to report
An analysis of 15 name-brand drugs and their "skinny label" generic counterparts found that competition from these counterparts saved Medicare Part D nearly $15 billion from 2015 to 2021. Skinny labeling allows generic drug ...
11 hours ago
0
0
More than half of older adults with intellectual disability take psychotropic medicines, shows study
The Examining Quality, Use and Impact of Psychotropic (Use) in older adults with intellectual disabilities (EQUIP) study, has revealed that more than half of older adults with intellectual disability take psychotropic medicines, ...
11 hours ago
0
0
Insomnia medication shows promise in treatment for alcohol use disorder
Researchers are recommending full-scale human trials after an insomnia drug helped a man withdraw from his 16 drinks-a-day addiction.
12 hours ago
0
0
Despite a 10-fold increase in ADHD prescriptions, too many New Zealanders are still going without
The number of people accessing medication for attention-deficit hyperactivity disorder (ADHD) in Aotearoa New Zealand increased significantly between 2006 and 2022. But the disorder is still underdiagnosed and under-treated ...
13 hours ago
0
0
Study finds metformin reduces COVID-19 viral load, viral rebound
A team of University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, can decrease the amount of COVID-19 virus in the body and lower the chances of the virus coming back strongly after ...
May 2, 2024
0
98
Will the movement to legalize psychedelics succeed?
Interest in psychedelics like psilocybin, mescaline, and LSD is on the rise for the first time in 50 years, as influencers, scientists, and entrepreneurs promote their therapeutic potential. Some municipalities have stopped ...
May 2, 2024
0
0
First effective treatment found for spitting cobra snakebite
Scientists have discovered a new snakebite treatment to prevent the devastating tissue damage caused by African spitting cobra venom.
May 1, 2024
0
30
Organ transplant drug may slow Alzheimer's disease progression
Protein imbalances that increase brain cell excitability may explain why individuals with Alzheimer's disease (AD) who also experience seizures demonstrate more rapid cognitive decline than those who do not experience seizures. ...
May 1, 2024
0
7
A better COVID treatment for the immunocompromised? Researchers create a non-toxic potential alternative to Paxlovid
A combination of two antiviral compounds may be a promising alternative to Paxlovid when treating COVID-19 in immunocompromised patients, according to Karen S. Anderson, Ph.D., professor of pharmacology and of molecular biophysics ...
Apr 30, 2024
0
52
Withdrawal of stop-smoking pill could lead to thousands of avoidable deaths
The disruption to the supply of a prescription medicine that helps people stop smoking may have led to thousands fewer people quitting each year in England, which will lead to avoidable deaths in future, suggests a new study ...
Apr 30, 2024
0
1
Study assesses health care providers' knowledge, attitudes, perception regarding Halal pharmaceuticals
The way religious beliefs and medical treatments intersect can really affect how people use medications and stick to their treatment plans. Lately, there's been talk about "Halal pharmaceuticals," which are drugs made to ...
Apr 30, 2024
0
0
Oral fungal infection treatment shows promise in preclinical trials
A novel oral amphotericin B (MAT2203) developed by Matinas BioPharma for treatment of invasive mucormycosis (IM) and other deadly invasive fungal infections, has demonstrated encouraging results in a series of preclinical ...
Apr 30, 2024
0
0
Protective effects of cyclosporine and NIM-811 in murine hepatic ischemia-reperfusion injury
During hepatic surgery or liver transplantation, the liver is vulnerable to ischemia-reperfusion injury (IRI), especially when vessels are compressed to control bleeding or during periods of ischemia. The hallmark of IRI ...
Apr 30, 2024
0
0
California strikes deal for cheaper overdose-reversing medication
California struck up a new deal with Amneal Pharmaceuticals on April 29 to bolster the state's supply of the opioid overdose-reversing medication naloxone at a much lower price for schools, police departments and others trying ...
Apr 30, 2024
0
0
Experimental drug shields pancreas from type 1 diabetes attack
Scientists at Johns Hopkins Medicine say that an experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1 diabetes in mice, and in some cases, to lengthen the animals' ...
Apr 29, 2024
0
11
Cabozantinib promising for advanced adrenocortical carcinoma
For patients with advanced adrenocortical carcinoma, cabozantinib shows promising efficacy, according to a study published online April 9 in The Lancet Oncology.
Apr 29, 2024
0
1
Curbing the price of novel diabetes and obesity medications
For years, Kasia Lipska, MD, MHS, associate professor of medicine (endocrinology) at Yale School of Medicine (YSM), has been advocating for affordable pricing of insulin, an essential —and sometimes lifesaving—drug for ...
Apr 29, 2024
0
0
The aspirin conundrum: Navigating negative results, age, aging dynamics and equity
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers ...
Apr 29, 2024
0
1
